Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer.

Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer.

BACKGROUND: When induction chemotherapy (IC) is used prior to chemoradiotherapy (CRT) in head and neck cancer (HNC), functional imaging (FI) may inform adaptation of treatment plans with the aim of optimising outcomes. Understanding the impact of IC on FI parameters is, therefore, essential. PURPOSE...

Full description

Bibliographic Details
Main Authors:	Powell, C, Schmidt, M, Borri, M, Koh, D, Partridge, M, Riddell, A, Cook, G, Bhide, SA, Nutting, C, Harrington, K, Newbold, K
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer.
by: Dandekar, P, et al.
Published: (2010)

Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
by: Newbold, K, et al.
Published: (2008)

Technical note: 9-month repositioning accuracy for functional response assessment in head and neck chemoradiotherapy.
by: Partridge, M, et al.
Published: (2012)

Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial.
by: Buettner, F, et al.
Published: (2012)

Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial.
by: Gulliford, S, et al.
Published: (2012)

Individualisation at sentencing
by: Roberts, JV, et al.
Published: (2018)

Individualised divergences
by: Bowman, CE
Published: (2015)

Individualised learning : types of individualised learning ; unit 2 [slaid]
Published: (1978)

Valproic acid: Growth inhibition of head and neck cancer by induction of terminal differentiation and senescence
by: Zain, R.B., et al.
Published: (2011)

The management of head-and-neck paragangliomas.
by: Capatina, C, et al.
Published: (2013)

Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck. A retrospective single center analysis.
by: Balermpas, P, et al.
Published: (2014)

Facial asymmetry in head and neck rhabdomyosarcoma survivors
by: Schoot, R, et al.
Published: (2017)

Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer.
by: Hale, J, et al.
Published: (2002)

SYNCOPE FROM HEAD AND NECK-CANCER
by: Macdonald, D, et al.
Published: (1982)

Individualising therapy for drug-sensitive tuberculosis
by: Esmail, H, et al.
Published: (2019)

Multi-atlas segmentation in head and neck CT scans
by: Arbisser, Amelia M
Published: (2013)

Development of neck dummy for head impact (soccer heading) experimental setup
by: Abdul Rahim, Zulkufli Ahmad
Published: (2013)

A legacy of tinnitus: multiple head and neck paragangliomas.
by: Tan, T, et al.
Published: (2009)

Manual of practical anatomy : head, neck and brain /
by: 309323 Nafis Ahmad Faruqi, et al.
Published: (2007)

Implementing individualised learning : in schools and colleges /
by: 397749 Davies, William James Keith
Published: (1978)

Current management of xerostomia in head and neck cancer patients
by: Nathan, C-AO, et al.
Published: (2023)

The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
by: Lander, Eric Steven
Published: (2013)

Relationship between neck muscle activation and head-neck response in low velocity frontal collision
by: Kak, D-Wing
Published: (2016)

Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer.
by: Kreimer, A, et al.
Published: (2013)

The relevance of adhesion molecules in the classification of squamous cell carcinoma of the head and neck.
by: Lieder, A, et al.
Published: (2005)

A Bourdieusian Analysis of Class and Migration: habitus and the individualising process
by: Oliver, C, et al.
Published: (2010)

The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.
by: Campbell, H, et al.
Published: (2011)

The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses
by: Campbell, H, et al.
Published: (2011)

Three−dimensional visualisation of cutaneous head and neck melanoma lymphoscintigraphy data
by: H.M., R, et al.
Published: (2008)

Weight loss in post-chemoradiotherapy head and neck cancer patients
by: Abu Zaid, Zalina, et al.
Published: (2022)

British Association of Head and Neck Oncologists (BAHNO) standards 2020
by: Schache, A, et al.
Published: (2021)

Towards globalization of Indonesian multidisciplinary head and neck surgery and oncology
by: , I. Bing Tan
Published: (2007)

Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer.
by: Beasley, N, et al.
Published: (2002)

Diagnostic and surgical imaging anatomy : brain, head and neck, spine /
by: Macdonald, Andre J.
Published: (2007)

Dose-individualisation for lung cancer radiotherapy - are we ready?
by: Malik, Z, et al.
Published: (2007)

Individualising the use of radiotherapy for the treatment of people with Hodgkin lymphoma
by: Shakir, R
Published: (2022)

Adversarial de-confounding in individualised treatment effects estimation
by: Chauhan, VK, et al.
Published: (2023)

Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.
by: Isaac, N, et al.
Published: (2002)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
by: Mukherjee, S, et al.
Published: (2015)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
by: Mukherjee, S, et al.
Published: (2015)